Publication | Closed Access

Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-κB/IκBα transcriptional complex

ImmunodeficienciesImmunologyImmune RegulationClinical SignsOral AdministrationInnate ImmunityImmune SystemImmunotherapyImmune DysregulationImmunopathologyAllergyAutoimmune DiseaseImmune SurveillanceAutoimmunityAutoimmune ResearchHumoral ImmunityImmune FunctionImmunologic DiseaseImmune Cell DevelopmentExperimental Autoimmune EncephalomyelitisMedicineViral Immunity